296 related articles for article (PubMed ID: 31811874)
21. Oxaliplatin-induced neurotoxicity and the development of neuropathy.
Krishnan AV; Goldstein D; Friedlander M; Kiernan MC
Muscle Nerve; 2005 Jul; 32(1):51-60. PubMed ID: 15880395
[TBL] [Abstract][Full Text] [Related]
22. Renin-Angiotensin-Aldosterone System Inhibitors Prevent the Onset of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Multicenter Study and in Vitro Evaluation.
Uchida M; Ushio S; Niimura T; Takechi K; Kawazoe H; Hidaka N; Tanaka A; Araki H; Zamami Y; Ishizawa K; Kitamura Y; Sendou T; Kawasaki H; Namba H; Shibata K; Tanaka M; Takatori S
Biol Pharm Bull; 2022 Feb; 45(2):226-234. PubMed ID: 34803077
[TBL] [Abstract][Full Text] [Related]
23. Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors.
Potenzieri A; Riva B; Rigolio R; Chiorazzi A; Pozzi E; Ballarini E; Cavaletti G; Genazzani AA
Pain; 2020 Feb; 161(2):405-415. PubMed ID: 31634341
[TBL] [Abstract][Full Text] [Related]
24. Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity.
Nepal MR; Taheri H; Li Y; Talebi Z; Uddin ME; Jin Y; DiGiacomo DF; Gibson AA; Lustberg MB; Hu S; Sparreboom A
Cancer Res Commun; 2022 Nov; 2(11):1334-1343. PubMed ID: 36506732
[TBL] [Abstract][Full Text] [Related]
25. Danggui Sini decoction protects against oxaliplatin-induced peripheral neuropathy in rats.
Ding R; Wang Y; Zhu JP; Lu WG; Wei GL; Gu ZC; An ZT; Huo JG
J Integr Neurosci; 2020 Dec; 19(4):663-671. PubMed ID: 33378840
[TBL] [Abstract][Full Text] [Related]
26. Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats.
Kono T; Suzuki Y; Mizuno K; Miyagi C; Omiya Y; Sekine H; Mizuhara Y; Miyano K; Kase Y; Uezono Y
Sci Rep; 2015 Nov; 5():16078. PubMed ID: 26542342
[TBL] [Abstract][Full Text] [Related]
27. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.
Lersch C; Schmelz R; Eckel F; Erdmann J; Mayr M; Schulte-Frohlinde E; Quasthoff S; Grosskreutz J; Adelsberger H
Clin Colorectal Cancer; 2002 May; 2(1):54-8. PubMed ID: 12453338
[TBL] [Abstract][Full Text] [Related]
28. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice.
Renn CL; Carozzi VA; Rhee P; Gallop D; Dorsey SG; Cavaletti G
Mol Pain; 2011 Apr; 7():29. PubMed ID: 21521528
[TBL] [Abstract][Full Text] [Related]
29. Platinum accumulation in oxaliplatin-induced peripheral neuropathy.
Wei G; Gu Z; Gu J; Yu J; Huang X; Qin F; Li L; Ding R; Huo J
J Peripher Nerv Syst; 2021 Mar; 26(1):35-42. PubMed ID: 33462873
[TBL] [Abstract][Full Text] [Related]
30. Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy.
Areti A; Komirishetty P; Akuthota M; Malik RA; Kumar A
J Pineal Res; 2017 Apr; 62(3):. PubMed ID: 28118492
[TBL] [Abstract][Full Text] [Related]
31. The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity.
Pozzi E; Fumagalli G; Chiorazzi A; Canta A; Meregalli C; Monza L; Carozzi VA; Oggioni N; Rodriguez-Menendez V; Cavaletti G; Marmiroli P
Exp Neurol; 2020 Dec; 334():113458. PubMed ID: 32889007
[TBL] [Abstract][Full Text] [Related]
32. Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat.
Cavaletti G; Petruccioli MG; Marmiroli P; Rigolio R; Galbiati S; Zoia C; Ferrarese C; Tagliabue E; Dolci C; Bayssas M; Griffon Etienne G; Tredici G
Anticancer Res; 2002; 22(6C):4199-204. PubMed ID: 12553056
[TBL] [Abstract][Full Text] [Related]
33. Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
McHugh JC; Tryfonopoulos D; Fennelly D; Crown J; Connolly S
Eur J Cancer Care (Engl); 2012 Nov; 21(6):782-9. PubMed ID: 22594346
[TBL] [Abstract][Full Text] [Related]
34. Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy.
Cavaletti G; Marmiroli P
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32471028
[TBL] [Abstract][Full Text] [Related]
35. Oxaliplatin treatment changes the function of sensory nerves in rats.
Yamamoto S; Ono H; Kume K; Ohsawa M
J Pharmacol Sci; 2016 Apr; 130(4):189-93. PubMed ID: 26790975
[TBL] [Abstract][Full Text] [Related]
36. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
Joseph EK; Chen X; Bogen O; Levine JD
J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
[TBL] [Abstract][Full Text] [Related]
37. Early changes in tests of peripheral nerve function during oxaliplatin treatment and their correlation with chemotherapy-induced polyneuropathy symptoms and signs.
Krøigård T; Svendsen TK; Wirenfeldt M; Schrøder HD; Qvortrup C; Pfeiffer P; Gaist D; Sindrup SH
Eur J Neurol; 2020 Jan; 27(1):68-76. PubMed ID: 31373417
[TBL] [Abstract][Full Text] [Related]
38. An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with goshajinkigan and bushi.
Mizuno K; Shibata K; Komatsu R; Omiya Y; Kase Y; Koizumi S
Cancer Biol Ther; 2016 Nov; 17(11):1206-1212. PubMed ID: 27416484
[TBL] [Abstract][Full Text] [Related]
39. Nrf2 inhibits oxaliplatin-induced peripheral neuropathy via protection of mitochondrial function.
Yang Y; Luo L; Cai X; Fang Y; Wang J; Chen G; Yang J; Zhou Q; Sun X; Cheng X; Yan H; Lu W; Hu C; Cao P
Free Radic Biol Med; 2018 May; 120():13-24. PubMed ID: 29530794
[TBL] [Abstract][Full Text] [Related]
40. Ameliorative effects of aqueous extract of Forsythiae suspensa fruits on oxaliplatin-induced neurotoxicity in vitro and in vivo.
Yi JM; Shin S; Kim NS; Bang OS
BMC Complement Altern Med; 2019 Nov; 19(1):339. PubMed ID: 31783843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
